66 related articles for article (PubMed ID: 28304089)
1. Phosphorylated FADD is not prognostic for local control in T1-T2 supraglottic laryngeal carcinoma treated with radiotherapy.
Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; Langendijk JA; de Bock GH; Roodenburg JL; van der Laan BFAM; van der Wal JE; Schuuring E
Laryngoscope; 2017 Sep; 127(9):E301-E307. PubMed ID: 28304089
[TBL] [Abstract][Full Text] [Related]
2. ALCAM is a biomarker of tumor aggressiveness and worse prognosis in glottic laryngeal squamous cell carcinoma.
Nicolau-Neto P; Peryassú BC; de Carvalho FN; Souza-Santos PT; Valverde P; Nascimento CM; Costa I; Dias FL; Pinto LFR
Head Neck; 2024 Apr; 46(4):785-796. PubMed ID: 38196304
[TBL] [Abstract][Full Text] [Related]
3. DIRC3 and near NABP1 genetic polymorphisms are associated laryngeal squamous cell carcinoma patient survival.
Shen Z; Ren W; Bai Y; Chen Z; Li J; Li B; Jin T; Cao P; Shao Y
Oncotarget; 2016 Nov; 7(48):79596-79604. PubMed ID: 27793000
[TBL] [Abstract][Full Text] [Related]
4. Correlation between expression of Lin28B and C-myc in patients with laryngeal squamous cell carcinoma and clinicopathological features and prognosis.
Liao F; Cao Y; Huang M; Chu L; Wang T
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 48(2):165-171. PubMed ID: 36999462
[TBL] [Abstract][Full Text] [Related]
5. Prognostic values and clinical relationship of TYK2 in laryngeal squamous cell cancer.
Fang L; Wang W; Shi L; Chen Q; Rao X
Medicine (Baltimore); 2021 Aug; 100(34):e27062. PubMed ID: 34449498
[TBL] [Abstract][Full Text] [Related]
6. Early death in supraglottic laryngeal squamous cell carcinoma: A population-based study.
Liu J; Sun Q; Zhao J; Qin X; Gao T; Bai G; Chen G; Guo Z
Ear Nose Throat J; 2022 Feb; ():1455613221078184. PubMed ID: 35171058
[TBL] [Abstract][Full Text] [Related]
7. Multivariate analysis of prognostic factors in patients with lip squamous cell carcinoma after surgery.
Cheng H; Xu JH; He JQ; Yang XY; Shen XN; Xu XL
World J Surg Oncol; 2024 Jan; 22(1):35. PubMed ID: 38279138
[TBL] [Abstract][Full Text] [Related]
8. The minimal number of examined lymph nodes for accurate nodal staging and favorable prognosis in T1-2 supraglottic laryngeal squamous cell carcinoma.
Zhuge L; Wang S; Huang Z; Cai H; Li Z
Eur J Surg Oncol; 2023 Oct; 49(10):107041. PubMed ID: 37633174
[TBL] [Abstract][Full Text] [Related]
9. Tumor volumes in T3 supraglottic cancers treated with radiotherapy in the modern era: A study of the Canadian Head & Neck Collaborative Research Initiative.
Malik NH; Fu R; Hainc N; Noel CW; de Almeida JR; Hosni A; Huang SH; Yu E; Dzioba A; Leung A; Mangat A; MacNeil D; Nichols AC; Hiremath SB; Chakraborty S; Jooya A; Gaudet M; Johnson-Obaseki S; Whelan J; Forghani R; Hier MP; Morand G; Sultanem K; Dort J; Lysack J; Matthews W; Nakoneshny S; Gill G; Globerman A; Kerr P; Maralani P; Karam I; Eskander A
Head Neck; 2024 Mar; 46(3):561-570. PubMed ID: 38116716
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of gene expression models that predict clinical outcome in patients with early-stage laryngeal cancer.
Fountzilas E; Markou K; Vlachtsis K; Nikolaou A; Arapantoni-Dadioti P; Ntoula E; Tassopoulos G; Bobos M; Konstantinopoulos P; Fountzilas G; Spentzos D
Ann Oncol; 2012 Aug; 23(8):2146-2153. PubMed ID: 22219018
[TBL] [Abstract][Full Text] [Related]
11. IL-17 expression and prognosis of laryngeal squamous cell carcinoma.
Li Y; Chen M
Ear Nose Throat J; 2024 Feb; ():1455613241232500. PubMed ID: 38357743
[No Abstract] [Full Text] [Related]
12. Assessment of immune status of laryngeal squamous cell carcinoma can predict prognosis and guide treatment.
Wang X; Cao K; Guo E; Mao X; An C; Guo L; Zhang C; Guo J; Yang X; Sun J; Yang W; Li X; Miao S
Cancer Immunol Immunother; 2022 May; 71(5):1199-1220. PubMed ID: 34643766
[TBL] [Abstract][Full Text] [Related]
13. Value of routine follow-up for recurrence detection after treatment with curative intent for laryngeal squamous cell carcinoma.
van de Weerd C; Geurts SME; Vercoulen RJMT; van Veggel IHF; Brands MT; Marres HAM; Hermens RPMG; van Tol-Geerdink JJ; Kaanders JHAM; Takes RP
Eur J Surg Oncol; 2024 Jan; 50(1):107304. PubMed ID: 38043360
[TBL] [Abstract][Full Text] [Related]
14. The association of E2F1 and E2F2 single nucleotide polymorphisms with laryngeal squamous cell carcinoma pathomorphological features.
Jakstas T; Bartnykaite A; Padervinskis E; Vegiene A; Juozaityte E; Uloza V; Ugenskiene R
BMC Cancer; 2024 Feb; 24(1):214. PubMed ID: 38360622
[TBL] [Abstract][Full Text] [Related]
15. Outcome of radiotherapy for the treatment of laryngeal squamous cell carcinoma in the very elderly population.
Yariv O; Amitai N; Nachalon Y; Moore A; Popovtzer A
J Laryngol Otol; 2024 Apr; 138(4):443-447. PubMed ID: 36776099
[TBL] [Abstract][Full Text] [Related]
16. Role of Neck Dissection in Organ-Preservation for Glottic Squamous Cell Carcinoma.
Luna-Ortiz K; Reynoso-Noverón N; Zacarías-Ramón LC; Luna-Peteuil Z; García-Ortega DY
Indian J Otolaryngol Head Neck Surg; 2022 Dec; 74(Suppl 3):5865-5870. PubMed ID: 36742477
[TBL] [Abstract][Full Text] [Related]
17. Circulating levels of FoxP3, M2 (sCD163) and IGF-1 as potential biomarkers associated with Laryngeal Squamous Cell Carcinoma in Tunisian patients.
Mokni Baizig N; Ben ElHadj M; Hsairi M; Fourati A; Kamoun S; Houcine Y; Gritli S; Driss M
J Immunoassay Immunochem; 2024 Mar; 45(2):79-92. PubMed ID: 37936281
[TBL] [Abstract][Full Text] [Related]
18. CRM1 expression: association with high prognostic value in laryngeal cancer.
Özdaş T; Özdaş S; Canatar İ; Coşgun E; Şenyurt EB; Görgülü O
Turk J Med Sci; 2023 Aug; 53(4):909-923. PubMed ID: 38031942
[TBL] [Abstract][Full Text] [Related]
19. Predicting survival of advanced laryngeal squamous cell carcinoma: comparison of machine learning models and Cox regression models.
Zhang YF; Shen YJ; Huang Q; Wu CP; Zhou L; Ren HL
Sci Rep; 2023 Oct; 13(1):18498. PubMed ID: 37898687
[TBL] [Abstract][Full Text] [Related]
20. Biological tumor markers associated with local control after primary radiotherapy in laryngeal cancer: A systematic review.
Noordhuis MG; Kop EA; van der Vegt B; Langendijk JA; van der Laan BFAM; Schuuring E; de Bock GH
Clin Otolaryngol; 2020 Jul; 45(4):486-494. PubMed ID: 32246586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
